Mark Lewandowski

Mark Lewandowski has a diverse work experience in various biotechnology and pharmaceutical companies. Mark most recently worked at Dragonfly Therapeutics, Inc. as a Scientist I and has held roles such as a Principal Associate Scientist, Principal Research Associate, Staff Research Associate, and Senior Research Associate within the company. Prior to that, they worked at Amicus Therapeutics as an Associate Scientist in Biochemistry and Cell Biology, where they were responsible for designing downstream purification platforms and performing analytical assays. Mark also has experience at Pfizer as an Associate Scientist, collaborating on biosimilar and mAb purification projects, and at Moderna Therapeutics as an mRNA Production Associate, spearheading process development initiatives. Additionally, they have worked at Novartis Institutes for BioMedical Research as a Companion Diagnostics Manufacturing Associate, at Pall Life Sciences as an Applications Scientist, at Lonza as an R&D Process Development Associate, and at EMD Serono, Inc. as a Research Associate in the Cell Biology Group.

Mark Lewandowski attended The Hotchkiss School from 2002 to 2006 and earned a Diploma. Mark then enrolled in Northeastern University from 2007 to 2009, studying Biochemistry, but did not complete their degree as they transferred schools. From 2010 to 2012, Mark attended Worcester State University, where they obtained a Bachelor of Science (B.S.) degree in Biology, General. Further education history or details are not provided for Mark Lewandowski.